Expand LABD Menu
LABD MENU

LABD ETF Profile


Family: Direxion Shares
Name: Direxion Daily S&P Biotech Bear 3x Shares
Inception Date: 28-May-2015
Termination Date:
Investment Objective: The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.
Prospectus
Top 10 Holdings
Derivatives offset 309.8925%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP -90.1848%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP -52.7873%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP -46.6030%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP -44.9386%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP -43.8343%
GOLDMAN FINL SQ TRSRY INST 506 X9USDGSFC 42.3686%
DREYFUS GOVT CASH MAN INS X9USDDGCM 40.4211%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP -31.5446%
DREYFUS TRSRY SECURITIES CASH MGMT 8.7381%
Top 10 Holdings Weight: 91.5%
Number of Holdings: 11
Shares Outstanding: 11,366,024
Total Net Assets: 92,519,430
NAV: 8.13
Net Expense Ratio: 0.95%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor: Inverse (-3x)
Is Currency Hedged: No
US or Ex-US: Domestic